By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agendia is partnering with the University of Texas MD Anderson Cancer Center and the Netherlands Cancer Institute to use genomics and proteomics to better understand the biology of colorectal cancer, the Dutch firm announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.